儿童多系统炎症综合征（MIS-C）合并 COVID-19：同时发生的家族性川崎病病例的启示。
Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases.
机构信息
Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
出版信息
Int J Infect Dis. 2020 Aug;97:371-373. doi: 10.1016/j.ijid.2020.06.014. Epub 2020 Jun 14.
Abstract
Recently, an increasing number of SARS-CoV-2 patients with COVID-19 syndrome, which overlaps with Kawasaki Disease (KD), have been reported, supporting the suggestion that infection is one of the triggers of KD. We summarized the reports of simultaneous familial KD cases to better understand the etiopathogenesis of both KD and Multisystem Inflammatory Syndrome in Children (MIS-C) related to COVID-19. Here we discuss the etiology of these syndromes from the point of view of infection and genetic susceptibility.
摘要
最近，越来越多的 COVID-19 综合征合并川崎病（KD）的 SARS-CoV-2 患者被报道，这支持了感染是 KD 的触发因素之一的说法。我们总结了同时发生的家族性 KD 病例报告，以更好地了解 COVID-19 相关的 KD 和儿童多系统炎症综合征（MIS-C）的发病机制。在这里，我们从感染和遗传易感性的角度讨论这些综合征的病因。
相似文献
1
Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases.儿童多系统炎症综合征（MIS-C）合并 COVID-19：同时发生的家族性川崎病病例的启示。
Int J Infect Dis. 2020 Aug;97:371-373. doi: 10.1016/j.ijid.2020.06.014. Epub 2020 Jun 14.
2
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.儿童 COVID-19 相关多系统炎症综合征的免疫学。
Cell. 2020 Nov 12;183(4):968-981.e7. doi: 10.1016/j.cell.2020.09.016. Epub 2020 Sep 6.
3
Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.川崎病与儿童新型冠状病毒病相关的多系统炎症综合征之间的表型、易感性、自身免疫和免疫治疗。
Front Immunol. 2021 Feb 26;12:632890. doi: 10.3389/fimmu.2021.632890. eCollection 2021.
4
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.58 例与 SARS-CoV-2 相关的儿童炎症性多系统综合征的临床特征。
JAMA. 2020 Jul 21;324(3):259-269. doi: 10.1001/jama.2020.10369.
5
Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated With COVID-19 in the United States.美国与 COVID-19 相关的儿童多系统炎症综合征的超声心动图表现。
J Am Coll Cardiol. 2020 Oct 27;76(17):1947-1961. doi: 10.1016/j.jacc.2020.08.056. Epub 2020 Sep 2.
6
Multisystem Inflammatory Syndrome in Children in New York State.纽约州儿童多系统炎症综合征。
N Engl J Med. 2020 Jul 23;383(4):347-358. doi: 10.1056/NEJMoa2021756. Epub 2020 Jun 29.
7
Multisystem Inflammatory Syndrome in Children During the Coronavirus 2019 Pandemic: A Case Series.2019 年冠状病毒病大流行期间儿童多系统炎症综合征：病例系列研究。
J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):393-398. doi: 10.1093/jpids/piaa069.
8
Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.儿童感染 SARS-CoV-2 后发生的多系统炎症综合征：在高发病率地区大流行一年后。
Viruses. 2021 Oct 7;13(10):2022. doi: 10.3390/v13102022.
9
The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection.与 SARS-CoV-2 感染相关的川崎病样疾病的广泛谱。
Expert Rev Clin Immunol. 2020 Dec;16(12):1205-1215. doi: 10.1080/1744666X.2021.1847643. Epub 2020 Nov 25.
10
Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.新冠疫情期间法国疫区出现与 SARS-CoV-2 感染相关的川崎病：时间序列分析。
Lancet Child Adolesc Health. 2020 Sep;4(9):662-668. doi: 10.1016/S2352-4642(20)30175-9. Epub 2020 Jul 2.
引用本文的文献
1
Kawasaki disease in Colombia: A systematic review and contrast with multisystem inflammatory syndrome in children associated with COVID-19.哥伦比亚的川崎病：一项系统综述以及与儿童 COVID-19 相关多系统炎症综合征的对比
Rev Colomb Reumatol. 2022 Jun;29:S66-S76. doi: 10.1016/j.rcreu.2020.11.004. Epub 2021 Jan 28.
2
Risk of Kawasaki Disease/Multisystem Inflammatory Syndrome Following COVID-19 Vaccination in Korean Children: A Self-Controlled Case Series Study.韩国儿童接种新冠疫苗后发生川崎病/多系统炎症综合征的风险：一项自我对照病例系列研究。
J Korean Med Sci. 2025 Jan 20;40(3):e10. doi: 10.3346/jkms.2025.40.e10.
3
Efficacy, immunogenicity and safety of CoronaVac® in children and adolescents aged 6 months to 17 years: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial.CoronaVac® 在 6 月龄至 17 岁儿童和青少年中的有效性、免疫原性和安全性：一项多中心、随机、双盲、安慰剂对照的 III 期临床研究。
Nat Commun. 2024 Aug 6;15(1):6660. doi: 10.1038/s41467-024-50802-2.
4
Research perspective in the clinical management of Kawasaki disease.川崎病临床管理的研究视角
Front Pediatr. 2024 Jul 9;12:1415941. doi: 10.3389/fped.2024.1415941. eCollection 2024.
5
Neurological Manifestations of Coronavirus Disease 2019 and Mpox in Pediatric Patients and Their Management: A State-of-the-Art Systematic Review.新型冠状病毒病 2019 与猴痘在儿科患者中的神经表现及其治疗：最新系统评价。
Pediatr Neurol. 2023 Sep;146:65-78. doi: 10.1016/j.pediatrneurol.2023.05.011. Epub 2023 May 19.
6
Safety and Tolerability of COVID-19 Vaccine in Children With Epilepsy: A Prospective, Multicenter Study.儿童癫痫患者接种 COVID-19 疫苗的安全性和耐受性：一项前瞻性、多中心研究。
Pediatr Neurol. 2023 Mar;140:3-8. doi: 10.1016/j.pediatrneurol.2022.11.018. Epub 2022 Dec 5.
7
Barriers and facilitators of childhood COVID-19 vaccination among parents: A systematic review.父母对儿童新冠疫苗接种的阻碍因素与促进因素：一项系统综述
Front Pediatr. 2022 Nov 24;10:950406. doi: 10.3389/fped.2022.950406. eCollection 2022.
8
COVID-19 and cutaneous manifestations: A review of the published literature.新型冠状病毒肺炎与皮肤表现：文献复习。
J Cosmet Dermatol. 2023 Jan;22(1):4-10. doi: 10.1111/jocd.15477. Epub 2022 Nov 7.
9
Immunophenotyping of peripheral blood cells allows to discriminate MIS-C and Kawasaki disease.外周血细胞的免疫表型分析有助于区分儿童多系统炎症综合征和川崎病。
Transl Med Commun. 2022;7(1):22. doi: 10.1186/s41231-022-00128-2. Epub 2022 Sep 4.
10
After the virus has cleared-Can preclinical models be employed for Long COVID research?病毒清除后，能否使用临床前模型进行长新冠研究？
PLoS Pathog. 2022 Sep 7;18(9):e1010741. doi: 10.1371/journal.ppat.1010741. eCollection 2022 Sep.
本文引用的文献
1
Self-Reported Symptoms of COVID-19, Including Symptoms Most Predictive of SARS-CoV-2 Infection, Are Heritable.自我报告的 COVID-19 症状，包括最能预测 SARS-CoV-2 感染的症状，是可遗传的。
Twin Res Hum Genet. 2020 Dec;23(6):316-321. doi: 10.1017/thg.2020.85.
2
Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study.法国巴黎新冠疫情期间儿童川崎样多系统炎症综合征：前瞻性观察研究。
BMJ. 2020 Jun 3;369:m2094. doi: 10.1136/bmj.m2094.
3
Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic.儿童多系统炎症综合征伴发急性心力衰竭：全球 SARS-CoV-2 大流行背景下的临床观察
Circulation. 2020 Aug 4;142(5):429-436. doi: 10.1161/CIRCULATIONAHA.120.048360. Epub 2020 May 17.
4
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.SARS-CoV-2 疫情意大年夜利中间爆发严重川崎病样病：一项不雅察性队列研究。
Lancet. 2020 Jun 6;395(10239):1771-1778. doi: 10.1016/S0140-6736(20)31103-X. Epub 2020 May 13.
5
BCG-induced trained immunity: can it offer protection against COVID-19?BCG 诱导的训练免疫：能提供针对 COVID-19 的保护吗？
Nat Rev Immunol. 2020 Jun;20(6):335-337. doi: 10.1038/s41577-020-0337-y.
6
Variations in ORAI1 Gene Associated with Kawasaki Disease.与川崎病相关的ORAI1基因变异
PLoS One. 2016 Jan 20;11(1):e0145486. doi: 10.1371/journal.pone.0145486. eCollection 2016.
7
A genome-wide association study identifies three new risk loci for Kawasaki disease.一项全基因组关联研究鉴定出川崎病的三个新风险位点。
Nat Genet. 2012 Mar 25;44(5):517-21. doi: 10.1038/ng.2220.
8
Familial occurrence of Kawasaki syndrome in North America.北美川崎病的家族聚集性。
Arch Pediatr Adolesc Med. 2005 Sep;159(9):876-81. doi: 10.1001/archpedi.159.9.876.
9
Clinical features of patients with Kawasaki disease whose parents had the same disease.父母患有川崎病的川崎病患者的临床特征。
Arch Pediatr Adolesc Med. 2004 Dec;158(12):1166-9. doi: 10.1001/archpedi.158.12.1166.
Zotero 插件